Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Amyloidosis, Date of authorisation: 16/11/2011, Revision: 27, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 22 September 2023 - 14:03

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Amyloidosis, Date of authorisation: 16/11/2011, Revision: 27, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/vyndaqel

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters